Automated Confocal Microscopy

BD Pathway 855 High-Content Bioimager

Fluofarma owns a High Content Screening platform based on automated confocal microscopy. This innovative platform enables real-time confocal imaging with high quality images.


Automated Confocal Microscopy


Automated Platform: from liquid handling to data analysis

Versatility and flexibility:

- Multiple slide and multiwell plate formats
- Fixed cells, suspension or loosely adherent cells
- Controlled imaging chamber for live cell experimentation
- Laser-free illumination, large spectrum of fluorescent dyes

Fast and efficient:

- High quality images and reduced background fluorescence
- Easy conversion of endpoint assays to kinetic applications
- Flexible software: easy data classification & analysis

Breaking news

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal Cell Research.

    Read more [+]

  • Publication

    Fluofarma cited in a Biocompare featured article “Flow Cytometry Gets a Makeover”

    Read more [+]

  • Press Release

    Roche adopts Fluofarma’s high-content screening platform.

    Read more [+]

  • Scientific Publication

    Fluofarma is glad to announce a new scientific publication in the journal "Analytical Chemistry".

    Read more [+]

Roche adopts Fluofarma’s platform
October 19, 2009 – Fluofarma announced today that it entered into a multi-year agreement with Roche.
Read More



ALL NEWS